EP Plus Group Leverages 4,000 Clinics to Invite Taiwanese Companies to Co-create a $4 Billion ASEAN Healthcare Market

As the ASEAN healthcare industry moves towards greater digitalization and smart solutions, EP Plus Group Sdn Bhd, a leading healthcare player in the region, is in Taiwan to explore partnerships. The group is seeking new opportunities in treatments for gastrointestinal, neurological, respiratory, gynecological, and diabetes-related conditions, as well as in reproductive medicine and aesthetic products. With a robust network of over 4,000 partner clinics, EP Plus Group is not only a trusted brand among thousands of Southeast Asian healthcare professionals but also the exclusive distributor for more than 30 internationally renowned brands, playing a key role in driving medical innovation in the region.

According to a Fitch Solutions report, Malaysia’s medical device market is expected to grow at a 9.3% compound annual growth rate (CAGR) from 2023 to 2028, reaching MYR 16.6 billion (approximately USD 3.6 billion) by 2028. This growth is fueled by government investment in public healthcare infrastructure and the rising demand for medical tourism.

Amid the rapid development of smart healthcare and digital health across the ASEAN region, Taiwan's medical products and services are making significant inroads into local markets. In December 2022, the Institute for Biotechnology and Medicine Industry (IBMI) signed a memorandum of understanding with over 100 hospitals across ASEAN to establish smart healthcare environments and promote digital healthcare transformation. In June 2024, Taiwan's Deputy Minister of Economic Affairs, Chen Cheng-chi, emphasized that ASEAN is a strategic gateway for Taiwan’s high-tech medical products to enter global markets.

As a leader in the ASEAN healthcare sector, EP Plus Group has successfully integrated regional medical resources through its extensive clinic network, providing high-quality services to healthcare institutions across the region. At the Taiwan Healthcare+ Expo, EP Plus Group aims to collaborate with Taiwanese companies known for their innovative capabilities to expand markets for gastrointestinal and diabetes treatment products while exploring potential in the digital health and aesthetic medicine sectors.

EP Plus Group’s visit to Taiwan not only highlights its commitment to deepening its presence in the ASEAN market but also reflects the region’s growing demand for smart healthcare solutions. By combining Taiwan’s AI technologies with EP Plus Group’s extensive local network of clinics, this partnership has the potential to drive the creation of innovative medical services and capitalize on the vast opportunities in medical tourism and digital health.

● Also Want to Explore More Business Opportunities?
【Register for the 2024 Heathcare+ Expo Now to find the best partners! ▸】